CTSA Predoctoral T32 at the University of Michigan
CTSA Predoctoral T32 at the University of Michigan
批准号:
10620888
负责人:
VICKI L ELLINGROD
金额:
$54.13万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-01 至 2028-03-31
中文摘要
项目总结/摘要
在过去的15年里,密歇根州临床与健康研究所(MICHR)支持了一个多样化的
一组博士前博士和专业学位的学员,通过提供基础的计划,
富有成效的转化研究和科学事业。这些受训人员来自一所大学,
密歇根州(U-M)的11所学校和学院(包括医学,牙科,药学,公共卫生,护理,
社会工作,运动机能学和工程),以及密歇根大学以外的许多项目,包括更多
20多所历史悠久的黑人学院和大学,西班牙裔服务机构或部落学院
美国教育部认定的大学。课程毕业生撰写了
超过1500篇科学出版物和领先的研究项目,由1750万美元的校外资助支持
支持,超过70%的人仍然从事科学。MICHR的新T32计划特别强大,
在其强有力的评估和坚持基本的方案要素,其中包括能力-
基础教育,研究技能的正式评估,导师培训和定期导师会议,定期
使用个人发展计划,并在团队科学,科学严谨性和责任教育,
进行研究。我们的计划是由一组优秀的科学导师支持,
9900万美元的校外资金,欢迎我们的T32学员进入他们非常成功的多学科和
合作研究项目。翻译科学中的MICHR T32将招募不同的
谁是早期在健康相关的博士课程与支持两到三年的学员,或专业
希望休学一年接受转化科学培训的学生。这个新
该计划将建立在我们以前成功的TL 1的基础上,并利用
U-M应对不断变化的学员需求和转化研究和科学的新兴趋势。大体上,
我们的T32计划的重点主题领域将通过以下方式与人权专员办事处的愿景和主题重点完全结合起来
以下目标:1)为T32学员提供精确的准备,以进一步开展翻译研究
技能; 2)加强T32学员的科学社交网络,以进一步推进他们的转化研究管道
参与; 3)培养T32学员谁是多才多艺的沟通者,以推进他们不断发展的职业生涯。的
MICHR博士前T32在翻译科学的预期成果将导致实施
提供新的培训机会,使教育民主化,
提供灵活、个性化的培训选项。我们的新举措将加强我们的学员的科学社会
网络,以促进职业发展,提高沟通技能,同时还提供更多
有机会获得MICHR和密歇根大学的资源,使我们能够建立和保留强大的下一批-
产生转化研究和转化科学团队的领导者。
英文摘要
Project Summary/Abstract
Over the last 15 years, the Michigan Institute for Clinical & Health Research (MICHR) has supported a diverse
group of predoctoral PhD and professional degree trainees through programs that provide the foundation for
productive translational research and science careers. These trainees come to us from one of the University of
Michigan's (U-M) 11 Schools and Colleges (including Medicine, Dentistry, Pharmacy, Public Health, Nursing,
Social Work, Kinesiology, and Engineering), as well as numerous programs outside of U-M, including more
than 20 Historically Black Colleges & Universities, Hispanic Serving Institutions, or Tribal Colleges &
Universities as identified by the United States Department of Education. Program graduates have authored
more than 1500 scientific publications and lead research programs supported by $17.5M in extramural grant
support, with greater than 70% remaining engaged in science. MICHR's new T32 program is particularly strong
in its robust evaluation and adherence to foundational programmatic elements, which include competency-
based education, formal assessment of research skills, mentor training and regular mentor meetings, regular
use of individual development plans, and education in team science, scientific rigor, and the responsible
conduct of research. Our program is supported by an outstanding group of scientific mentors with more than
$99M in extramural funds, who welcome our T32 trainees into their highly successful multidisciplinary and
collaborative research programs. The MICHR T32 in translational science will recruit diverse cohorts of
trainees who are early in a health-related PhD program with support for two to three years, or professional
students wishing to take a year out from their education to receive translational science training. This new
program will build on the foundation set by our previous successful TL1 and leverage the unique strengths of
U-M to respond to evolving trainee needs and emerging trends in translational research and science. Broadly,
our T32 program's thematic areas of focus will fully integrate with MICHR's vision and thematic focus through
the following Aims: 1) Provide T32 trainees with precision preparation to further their translational research
skills; 2) strengthen the scientific social networks of T32 trainees to further their translational research pipeline
engagement; 3) develop T32 trainees who are versatile communicators to advance their evolving careers. The
expected outcomes of the MICHR predoctoral T32 in translational science will result in the implementation of
new training opportunities that democratize education and facilitate trainee pathways to independence by
providing flexible, personalized training options. Our new initiatives will strengthen our trainees' scientific social
networks for greater career development and enhance communication skills while also providing more
opportunities to access MICHR and U-M resources, allowing us to build and retain strong cohorts of next-
generation translational research and translational science team leaders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CTSA K12 Program at the University of Michigan
-
批准号:10621008
-
项目类别:
-
资助金额:$162.0万
-
财政年份:2023
-
负责人:VICKI L ELLINGROD
-
依托单位:
Institutional Career Development Core
-
批准号:9414515
-
项目类别:
-
资助金额:$138.29万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Development, Implementation and AssessMent of Novel Training in Domain-based Competencies (DIAMOND)
-
批准号:9319951
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Institutional Career Development Core
-
批准号:10116515
-
项目类别:
-
资助金额:$138.29万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics - Gender Supplement
-
批准号:8797754
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8578175
-
项目类别:
-
资助金额:$43.9万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:8019472
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:8213443
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8884655
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:9098787
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:7760595
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:9301028
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8705013
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8931314
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:7617851
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:7040750
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2004
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6905615
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6529325
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6649155
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6366012
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
海外基金